PureLift GLOW or CurrentBody Skin LED Mask, 750 LEDs and No Irradiance Figure
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
CurrentBody's mask is the most heavily marketed in this category and the least legible, because LED counts are published and power figures are not.
This article compares the two on what decides the result you actually see, such as:
- why 750 LEDs tells you nothing about dose
- the irradiance figures that exist only in the FDA filings
- how Series 2 and Series 3 differ, and which one you are buying
- what six wavelengths at once actually means
- what GLOW does that no mask does
and many more!
The figures below came from regulatory filings, because the product page has none of them.
Key Points:
The current CurrentBody Skin mask is Series 3 at $569.99, running 633, 830, 1072, 415, 532 and 590 nm across a published count of 750 LED bulbs.
No irradiance and no dose appear on the product page, and no clearance number or country of manufacture either.
Its FDA filings do publish figures: Series 2 at 18 J/cm2, and Series 3 at 13 to 26 mW/cm2 depending on wavelength.
At ten minutes the red mode on Series 3 works out at roughly 15.6 J/cm2, which is a reasonable dose and less than the Series 2 figure it replaced.
PureLift GLOW is $999 and publishes 1.13 W/m2 and 678 J/m2 for its light, plus 9 mA at 500 ohms for the current.
Why 750 LEDs is not a specification
An LED count tells you how many emitters are in the mask, not how much light each one produces or how much reaches your skin.
Brands also count differently: HigherDOSE publishes 66 dual-core LEDs described as 132 diodes, and CurrentBody's own FDA filing lists a figure that does not match the 750 on the page, most likely a diodes-against-packages difference.
So the number on the box is not comparable between brands and, as it turns out, not always within one brand.
Irradiance and dose are comparable, which is presumably why they are the two figures that go missing.
Where CurrentBody's numbers actually live
The Series 2 filing publishes a delivered dose of 18 J/cm2, which is among the clearer figures in the category.
The Series 3 filing publishes per-wavelength irradiance from 5 mW/cm2 at 532 nm up to 26 mW/cm2 at 633 nm.
Neither set appears on the page where you buy the mask.
We have written separately about this pattern across the category, where the regulator gets the engineering and the customer gets adjectives.
Credit where it is due: the figures are filed and specific, and a buyer who knows to look can find them.
Which mask you are buying
Series 3 is the current model and Series 2 still appears in comparison tables and bundles, so check which one is in your basket.
Series 2 holds its own clearance and Series 3 holds another, and the newer mask adds wavelengths rather than power.
Six wavelengths delivered together sounds more complete than two, and it also divides the available power across more emitters, which is why the red figure on Series 3 sits below the Series 2 dose.
More wavelengths is a design choice rather than an upgrade, and the brand does not frame it that way.
On light, the mask wins
GLOW publishes 1.13 W/m2 and 678 J/m2 over ten minutes, which converts to 0.113 mW/cm2 and 0.068 J/cm2.
Against roughly 15 to 18 J/cm2 from the CurrentBody mask, there is no version of the arithmetic where GLOW delivers more light, and we publish the conversion so you can check it.
A mask also covers the whole face at once while a probe covers what you hold it against.
If the light dose is what you are paying for, the mask is the better purchase and costs a little over half what GLOW does.
What GLOW adds
Nine technologies on one dial: Infusion, iontophoresis, nanocurrent, microcurrent, EMS, PDM, PDM++, blue at 465 nm and red at 634 nm.
It reaches 9 mA at 500 ohms with the diamond-faceted probe, which is the band where the muscle actually contracts.
Kavanagh and colleagues measured an 18.6 percent increase in cheek muscle thickness over twelve weeks at motor-level stimulation (10.1111/jocd.12007), and no mask at any irradiance produces that, because light is not current.
GLOW also runs a serum delivery pass with any water-based serum, is cleared under K243587, and is made in Japan in an ISO 13485 facility.
Which to buy
Buy the CurrentBody mask if texture, tone and fine lines are the concern and you want hands-free treatment across the whole face.
Buy PureLift GLOW if the lower face has started to drop, because that is a muscle question no mask answers.
Buy both and run GLOW first, then the mask, on skin that has just had circulation brought to it.
This comparison sits inside our full map of the category, where we set out all 33 devices we track, what each one carries and what each brand publishes: Nine Technologies on One Dial, What the Rest of the Market Actually Carries.
Prices and specifications verified on 21 September 2026 against each brand's own published material and the FDA 510(k) database.